Hepatic ischemia-reperfusion and mitochondrial quality control: potential therapeutic targets
Junqi Wang(Chinese University of Hong Kong), Meng Miao(Chinese Academy of Medical Sciences & Peking Union Medical College), Zhijiang Guo(Chinese University of Hong Kong), H. Zhou(Chinese PLA General Hospital), Wenkai Fu(Beijing Hospital of Traditional Chinese Medicine), Hongshuo Shi(Shandong University of Traditional Chinese Medicine), Xing Chang(Chinese Academy of Medical Sciences & Peking Union Medical College), Nan Lü(Nanyang Technological University)
Cited by 6
Related Papers
Emerging insights into the pathogenesis and therapeutic strategies for vascular endothelial injury-associated diseases: focus on mitochondrial dysfunction
|Angiogenesis|2024|215
Essential role for TrpC5-containing extracellular vesicles in breast cancer with chemotherapeutic resistance
|Proceedings of the National Academy of Sciences|2014|177
Nuclear receptor subfamily 4 group A member 1 promotes myocardial ischemia/reperfusion injury through inducing mitochondrial fission factor-mediated mitochondrial fragmentation and inhibiting FUN14 domain containing 1-depedent mitophagy
|International Journal of Biological Sciences|2024|165
New insights into the role of mitochondrial metabolic dysregulation and immune infiltration in septic cardiomyopathy by integrated bioinformatics analysis and experimental validation
|Cellular & Molecular Biology Letters|2024|148
Label-free microfluidic cell sorting and detection for rapid blood analysis
|Lab on a Chip|2023|135